Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientist regenerate living organ for the first time
A team of scientists at the University of Edinburgh have regenerated the thymus in old mice, potentially boosting their immune system.
A team of scientists at the University of Edinburgh have regenerated the thymus in old mice, potentially boosting their immune system.

Mouse study offers potential treatment for disease and old age

Scientists at the University of Edinburgh, have for the first time succeeded in regenerating a living organ.

The thymus is an organ in the body located next to the heart that produces important immune cells but which shuts down with age.

The scientific team reactivated a natural mechanism to rejuvenate the thymus in very old mice. After treatment, the regenerated organ was similar to that found in a young mouse.

The project could pave the way for new treatments for people with damaged immune systems and genetic conditions that affect thymus development.
Researchers from the Medical Research Council Centre for Regenerative Medicine at the university were behind the study.

They targeted a protein produced by cells of the thymus - called FOXN1 - which helps to control how important genes are switched on.
By increasing levels of FOXN1, the team instructed stem cell-like cells to rebuild the organ.

The function of the thymus was restored and the mice began making more white blood T cells, which are important for fighting off infection.
It is not yet clear however, whether the immune system of the mice was improved.

Professor Clare Blackburn from the MRC Centre said: "Our results suggest that targeting the same pathway in humans may improve thymus function and therefore boost immunity in elderly patients, or those with a suppressed immune system.

"However, before we test this in humans we need to carry out more work to make sure the process can be tightly controlled."

The thymus deteriorates with age, which is why older people are often more susceptible to infections such as flu.

The discovery could also offer hope to patients with DiGeorge syndrome, a genetic condition that causes the thymus to not develop properly.

"One of the key goals in regenerative medicine is harnessing the body’s own repair mechanisms and manipulating these in a controlled way to treat disease," said Dr Rob Buckle, MRC head of regenerative medicine.

"This interesting study suggests that organ regeneration in a mammal can be directed by manipulation of a single protein, which is likely to have broad implications for other areas of regenerative biology."

Image by Rama

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.